Timothy R. Wright

Chief Executive Officer & Director at MiMedx Group, Inc.

Timothy R. Wright

Timothy R. Wright

Chief Executive Officer & Director at MiMedx Group, Inc.

Overview
Career Highlights

Xanodyne Pharmaceuticals, Inc.
AAIPharma, Inc.
MiMedx Group, Inc.

RelSci Relationships

2000

Number of Boards

8

Birthday

1958

Age

63

Relationships
RelSci Relationships are individuals Timothy R. Wright likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chairman, Chief Executive Officer & Co-Founder at Agenus Inc.

Relationship likelihood: Strong

Operating Partner at Shore Capital Partners LLC

Relationship likelihood: Strong

Former Chief Resident at Cleveland Clinic

Relationship likelihood: Strong

President at The Petit Group LLC

Relationship likelihood: Strong

Chief Financial Officer at MiMedx Group, Inc.

Relationship likelihood: Strong

General Counsel & Secretary at MiMedx Group, Inc.

Relationship likelihood: Strong

Chief Compliance Officer at MiMedx Group, Inc.

Relationship likelihood: Strong

Senior Vice President & Chief Accounting Officer at MiMedx Group, Inc.

Relationship likelihood: Strong

Executive Vice President & Chief Commercial Officer at MiMedx Group, Inc.

Relationship likelihood: Strong

Chief Medical Officer at MiMedx Group, Inc.

Relationship likelihood: Strong

Paths to Timothy R. Wright
Potential Connections via
Relationship Science
You
Timothy R. Wright
Chief Executive Officer & Director at MiMedx Group, Inc.
Education
BSc
Class of 1981

The Ohio State University, commonly referred to as Ohio State or OSU, is a public research university in Columbus, Ohio. Founded in 1870, as a land-grant university and ninth university in Ohio with the Morrill Act of 1862, the university was originally known as the Ohio Agricultural and Mechanical College.

Career History
Chief Executive Officer & Director
2019 - Current

MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane; EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matri derived from the placental disc and other placental tissue. The company was founded on July 30, 1985 and is headquartered in Marietta, GA.

President & Chief Executive Officer
2017 - 2018

M2Gen Corp. provides informatics-based solutions to accelerate the discovery, development, and delivery of personalized medicine. Its solutions include Total Cancer Care Protocol and ORIEN Avatar. The company was founded by William S. Dalton in 2006 and is headquartered in Tampa, FL.

Executive Vice President-Strategy & Business Development
2015 - 2017

Teva is a global generic pharmaceuticals leader and one of the top 15 pharmaceutical companies in the world. Headquartered in Israel, Teva operates in 60 countries and has 46,000 employees worldwide. Established in 1901, Teva takes great pride in its long tradition of leadership and dedication to excellence

Boards & Committees
Director
2007 - 2010

CeNeS Pharmaceuticals Plc engages in the discovery and development of drugs. The company was founded by Alan Gilbert Goodman in 1997 and is headquartered in Cambridge, the United Kingdom.

Chairman
2006 - 2007

ParagonRx International LLC provides pharmaceutical risk management, medication consultancy and marketing consultancy services. It offers systematic risk assessment, clinical trial process mapping, risk management plan design, and quality risk management. The company was founded in 2001 and is headquartered in Newark, DE.

Member, Board of Directors
2004 - Prior

AAIPharma, Inc. provides product development services to the pharmaceutical, biotechnology and medical device industries. Its services include drug delivery technologies, contract manufacturing, clinical packaging and distribution and bioanalytical services. The company was founded in 1979 and is headquartered in Wilmington, NC.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Timothy R. Wright. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Timothy R. Wright's profile does not indicate a business or promotional relationship of any kind between RelSci and Timothy R. Wright.